Physician profile
Eileen Hou
NPI 1558715508
$1,792.33
in general payments reported to CMS, 2019-2025
16 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.40 · 2022: $1,063 · 2023: $232 · 2024: $163 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $1,024.78 | 2022 | |
| Hologic Sales and Service, LLC | $163.41 | 2022-2025 | Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $124.97 | 2023 | |
| Shield Therapeutics INC | $116.14 | 2024-2025 | |
| Sage Therapeutics, LLC | $79.60 | 2025 | Zurzuvae |
| Regeneron Healthcare Solutions, INC. | $56.83 | 2024-2025 | Dupixent |
| Supernus Pharmaceuticals, INC. | $42.17 | 2025 | Qelbree |
| Exact Sciences Corporation | $32.95 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $25.58 | 2025 | Wegovy |
| Hologic INC | $21.98 | 2021 | |
| Qiagen, LLC | $21.31 | 2024 | |
| Mayne Pharma Commercial LLC | $20.69 | 2024 | |
| Lilly USA, LLC | $20.05 | 2025 | Zepbound, Mounjaro |
| Sumitomo Pharma America, INC. | $17.63 | 2025 | Myfembree |
| Dysis Medical, INC. | $12.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Hou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.